+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Global Ophthalmic Devices market set to grow to $60.8bn by 2025” says new Visiongain report

12 March 2020
Pharma

Visiongain has launched a new pharma report Global Ophthalmic Devices Market 2020-2030: Vision Care, Surgical, Diagnostics and Monitoring, OCT Machines, Autorefractor/Keratometer, Fundus Camera, Slit Lamp, OR Microscope, Optical Biometry, Tonometer, Perimeter, Cataract Surgery, Refractive Surgery, Vitro Retinal Surgery, Glaucoma Surgery, Spectacles, Contact Lenses, Daily Disposables.

The medical devices industry is one of the largest and fastest growing markets in the medical and pharmaceutical industries. Rise in geriatric population has led to a rise in ophthalmic conditions such as cataract and diabetic retinopathy. Moreover, rising disposable income, growing awareness of ophthalmic conditions coupled with favourable reimbursement policies of government will further boost the overall growth of ophthalmic surgical devices market.

The lead analyst of the report commented "The global ophthalmic surgical and vision care markets are large, dynamic and growing. As the world’s population grows and ages, the need for quality eye care is expanding and evolving. Advancements in technology have led to the replacement of conventional techniques and devices. There is an increasing prevalence of many eye diseases, especially those linked to chronic diseases such as diabetes. A relatively rich R&D pipeline will improve the diagnostics of ophthalmic diseases and outcomes of surgical procedures.

Current limitations of pharmaceutical treatments, as well of ophthalmic diagnostics and monitoring and surgical devices will continue to drive innovation. Patient compliance and cost effectiveness will be a key factor to consider in future device development."

Leading companies featured in the report include Abbott Medical Optics (AMO), Alcon, Bausch and Lomb (B&L), Carl Zeiss AG Meditec, Haag-Streit Holding AG, Hoya, Johnson & Johnson (J&J), Nidek, STAAR, TopCon, Zeimer Ophthalmic Solutions.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2024-2034

The global Pharma Wholesale and Distribution market is estimated at US$844.2 billion in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period 2024-2034.

20 February 2024

Read

Visiongain Publishes Biobanking Market Report 2024-2034

The global Biobanking market is estimated at US$75.4 billion in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period 2024-2034.

19 February 2024

Read

Visiongain Publishes Dermatological Drugs Market Report 2024-2034

The Dermatological Drugs market is estimated at US$30.47 billion in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period 2024-2034.

13 February 2024

Read

Visiongain Publishes Allergic Rhinitis Drugs Market Report 2024-2034

The global Allergic Rhinitis Drugs market is estimated at US$16,821.6 million in 2024 and is expected to register a CAGR of 2.7% from 2024 to 2034.

12 February 2024

Read